Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How have advances in our understanding of the molecular genetics of paediatric leukaemia led to improved targeted therapies for these diseases?

Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 Jan 2000

Szychot Elwira, Brodkiewicz Andrzej, Peregud-Pogorzelski Jarosław

Abstract excerpt

The term "leukaemia" refers to a large and heterogenous group of diseases, with treatment response and outcome dependent on the specific type of malignancy. New molecular methods allow us to specifically evaluate the type of disorder, and provide treatment of necessary intensity. The aim of this review is to provide insight into the progress in leukaemia treatment that had been possible due to advances in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia

Share to Molecular Diagnostic Techniques

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Predictive Value of Tests

Share to Remission Induction

Source

Identifiers

PMID: 24979521
DOI: 10.17219/acem/37148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How have advances in our understanding of the molecular genetics of paediatric leukaemia led to improved targeted therapies for these diseases?PMID 24979521Read ↗

Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications.Semantic proximity Read ↗

How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing.Semantic proximity Read ↗

[Suspicion of constitutional abnormality at diagnosis of childhood leukemia: Update of the leukemia committee of the French Society of Childhood Cancers].Semantic proximity Read ↗

Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis.Semantic proximity Read ↗

Molecular Markers of Pediatric Solid Tumors—Diagnosis, Optimizing Treatments, and Determining Susceptibility: Current State and Future DirectionsSemantic proximity Read ↗

Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current KnowledgeSemantic proximity Read ↗

Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.Semantic proximity Read ↗

Congenital neutropenia in the era of genomics: classification, diagnosis, and natural historySemantic proximity Read ↗

Pediatric Germline Predisposition to Myeloid Neoplasms.Semantic proximity Read ↗

Applying molecular epidemiology in pediatric leukemia.Semantic proximity Read ↗

Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions.Semantic proximity Read ↗

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.